Vanguard CIV H3N2 InjectableThis page contains information on Vanguard CIV H3N2 Injectable for veterinary use.
The information provided typically includes the following:
- Vanguard CIV H3N2 Injectable Indications
- Warnings and cautions for Vanguard CIV H3N2 Injectable
- Direction and dosage information for Vanguard CIV H3N2 Injectable
Vanguard CIV H3N2 InjectableThis treatment applies to the following species:
Canine Influenza Vaccine, H3N2
For use by, or under the supervision of, a veterinarian.
FOR EASIER STORAGE & VIEWING
● Pull down on the tab.
● Flip tab out and set bottom tray of vials inside top lid.
This product has been shown to be effective for the vaccination of healthy dogs 8 weeks of age or older against canine influenza (H3N2) virus infection. This product contains canine influenza virus A/Illinois/12191/2015. Duration of immunity has not been established. For more information regarding efficacy and safety data, go to productdata.aphis.usda.gov.
Directions For Use
Shake well. Aseptically administer 1 mL subcutaneously. Healthy dogs should receive 2 doses administered 3 weeks apart. Historically, annual revaccination with this product was recommended. The need for annual booster vaccinations has not been established for this product; consultation with a veterinarian or the manufacturer is recommended.
PrecautionsStore at 2°-8°C. Prolonged exposure to higher temperatures may adversely affect potency. Do not freeze. Sterilized syringes and needles should be used to administer this vaccine. Contains gentamicin as preservative. This product has not been tested in pregnant animals. In case of anaphylactoid reaction, administer epinephrine. Do not mix with other products. In case of human exposure, contact a physician.
Technical inquiries should be directed to Zoetis Inc. Veterinary Services, (888) 963-8471.
VLN 190/PCN 15P5.20
Zoetis Inc., Kalamazoo, MI 49007, USA
25 Vials (1 dose: 1 mL)
333 PORTAGE STREET, KALAMAZOO, MI, 49007
Copyright © 2022 Animalytix LLC. Updated: 2022-11-29